Dark

Check out our Level2View

CDMOP
Avid Bioservices, Inc. 10.50% Series E Convertible Preferred Stock
stock NASDAQ

Inactive

Apr 12, 2021

25.06USD+0.001%(+0.00)12,466

Pre-market

0.00USD-100.000%(-25.06)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 10, 2022

08:05AM EST Avid Bioservices Announces Official Opening of Second Downstream GlobeNewswire Inc

Dec 7, 2021

04:05PM EST Avid Bioservices Reports Financial Results for Second Quarter GlobeNewswire Inc

Nov 30, 2021

04:05PM EST Avid Bioservices to Report Financial Results for Second Quarter of GlobeNewswire Inc

Nov 4, 2021

08:05AM EDT Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice GlobeNewswire Inc

Oct 26, 2021

08:05AM EDT Avid Bioservices to Join S&P SmallCap 600 Index GlobeNewswire Inc

Oct 14, 2021

08:05AM EDT Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market GlobeNewswire Inc

Oct 7, 2021

08:05AM EDT Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial GlobeNewswire Inc

Sep 8, 2021

04:05PM EDT Avid Bioservices Reports Financial Results for First Quarter Ended GlobeNewswire Inc

Sep 2, 2021

04:05PM EDT Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that the company will participate in two upcoming investor conferences. GlobeNewswire Inc

Sep 1, 2021

04:05PM EDT Avid Bioservices to Report Financial Results for First Quarter of GlobeNewswire Inc

Jul 1, 2021

08:05AM EDT Avid Bioservices Announces Appointment of Esther M. Alegria, GlobeNewswire Inc

Jun 29, 2021

04:05PM EDT -- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- GlobeNewswire Inc

Jun 22, 2021

04:05PM EDT Avid Bioservices to Report Financial Results For Quarter and GlobeNewswire Inc

May 25, 2021

08:05AM EDT Avid Bioservices to Serve as Commercial Manufacturer for ADC GlobeNewswire Inc

Apr 15, 2021

04:05PM EDT Avid Bioservices Announces Completion of Redemption of Series E GlobeNewswire Inc

Mar 17, 2021

08:05AM EDT Avid Bioservices to Participate in KeyBanc Capital Markets Life GlobeNewswire Inc

Mar 10, 2021

12:20AM EST Avid Bioservices, Inc. Announces Pricing of $125 Million Offering GlobeNewswire Inc

Mar 8, 2021

05:01PM EST Avid Bioservices, Inc. Announces Proposed $125 Million Offering of GlobeNewswire Inc

04:05PM EST Avid Bioservices Reports Financial Results for Third Quarter GlobeNewswire Inc

Mar 3, 2021

04:05PM EST Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

Mar 1, 2021

04:05PM EST Avid Bioservices to Report Financial Results for Third Quarter of GlobeNewswire Inc

Feb 22, 2021

08:12AM EST Avid Bioservices Highlights Beginning Of Phase 2 Of Its Myford Manufacturing Capacity Expansion Plan Benzinga

08:05AM EST Build Out of Myford Facility Will Expand Current Footprint to Include Second Manufacturing Train with Both Upstream and Downstream Processing Suites GlobeNewswire Inc

Feb 3, 2021

07:02AM EST Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement For COVID-19 Therapeutic Candidate Lenzilumab In Support Of Potential EUA Filing Benzinga

07:00AM EST Humanigen and Avid Bioservices Enter into cGMP Manufacturing GlobeNewswire Inc

Dec 14, 2020

04:05PM EST Avid Bioservices Announces Closing of Public Offering of Common Stock GlobeNewswire Inc

Dec 10, 2020

09:01AM EST Avid Bioservices Announces Pricing Of 3,333,335 Shares Of Stock At $9/Share Benzinga

09:00AM EST Avid Bioservices Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc

Dec 9, 2020

04:49PM EST Avid Bioservices Announces Proposed Public Offering Of Common Stock; Size Not Disclosed Benzinga

04:45PM EST Avid Bioservices Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

Dec 7, 2020

04:05PM EST Avid Bioservices Announces Appointment of Jeanne Thoma to Board of GlobeNewswire Inc

Dec 2, 2020

04:05PM EST Avid Bioservices Reports Financial Results for Second Quarter GlobeNewswire Inc

Dec 1, 2020

04:05PM EST Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

Nov 24, 2020

04:05PM EST Avid Bioservices to Report Financial Results for Second Quarter of GlobeNewswire Inc

Sep 15, 2020

04:05PM EDT Avid Bioservices Announces Move to Virtual-Only Annual Meeting of GlobeNewswire Inc

Sep 1, 2020

04:05PM EDT Avid Bioservices Reports Financial Results for First Quarter Ended GlobeNewswire Inc

Aug 31, 2020

04:05PM EDT Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

Aug 26, 2020

08:11AM EDT Avid Bioservices Selected By Mapp Biopharmaceutical, Inc. For Clinical Development Of Novel Human Monoclonal Antiviral Antibody Benzinga

08:05AM EDT Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for GlobeNewswire Inc

Aug 25, 2020

04:05PM EDT Avid Bioservices to Report Financial Results for First Quarter of GlobeNewswire Inc

Aug 20, 2020

08:37AM EDT Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine Benzinga

08:33AM EDT Oragenics And Avid Bioservices Enter Process Development And drug Substance Manufacturing Agreement RTTNews

08:30AM EDT Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine Business Wire

Jul 28, 2020

08:08AM EDT Avid Bioservices And Argonaut Manufacturing Services Enter Agreement To Offer Biotechnology And Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing And Drug Product Parenteral Manufacturing Benzinga

08:05AM EDT Avid Bioservices and Argonaut Manufacturing Services Enter GlobeNewswire Inc

Share